The therapeutic potential of the pharmacological inhibition of PBEF/NAMPT/Visfatin in inflammatory bowel disease

被引：0
|
作者：
Gerner, R. [1 ]
Wieser, V. [1 ]
Bichler, A. [1 ]
Moschen, A. [1 ]
Tilg, H. [1 ]
机构：
[1] Univ Innsbruck, Dept Internal Med 1, A-6020 Innsbruck, Austria
来源：
JOURNAL OF CROHNS & COLITIS | 2014年 / 8卷
关键词：
D O I：
10.1016/S1873-9946(14)60130-6
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P006
引用
收藏
页码：S67 / S67
页数：1
相关论文
共 50 条
  • [41] Polyoxometalate nanoclusters: A potential preventative and therapeutic drug for inflammatory bowel disease
    Wang, Jingguo
    Tao, Zhenchao
    Tian, Tian
    Qiu, Jun
    Qian, Haisheng
    Zha, Zhengbao
    Miao, Zhaohua
    Ma, Yan
    Wang, Hua
    CHEMICAL ENGINEERING JOURNAL, 2021, 416
  • [42] BUDESONIDE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY IN INFLAMMATORY BOWEL-DISEASE
    SPENCER, CM
    MCTAVISH, D
    DRUGS, 1995, 50 (05) : 854 - 872
  • [43] Pharmacological inhibition of CCR9 is a novel approach in the treatment of inflammatory bowel disease
    Bekker, P.
    Keshav, S.
    Wei, Z.
    Ertl, L.
    Wang, Y.
    Lai, N.
    Wright, J.
    Ungashe, S.
    Schall, Thomas
    INFLAMMATION RESEARCH, 2007, 56 : S350 - S350
  • [44] Therapeutic inhibition of the JAK-STAT pathway in the treatment of inflammatory bowel disease
    Chen, Zihan
    Jiang, Ping
    Su, Dan
    Zhao, Yu
    Zhang, Mingming
    CYTOKINE & GROWTH FACTOR REVIEWS, 2024, 79 : 1 - 15
  • [45] PDE4 Inhibition and Inflammatory Bowel Disease: A Novel Therapeutic Avenue
    Spadaccini, Marco
    D'Alessio, Silvia
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (06)
  • [46] Inflammatory Bowel Disease: Perioperative Pharmacological Considerations
    Kumar, Ajay
    Auron, Moises
    Aneja, Ashish
    Mohr, Franziska
    Jain, Alok
    Shen, Bo
    MAYO CLINIC PROCEEDINGS, 2011, 86 (08) : 748 - 757
  • [47] PHARMACOLOGICAL THERAPY FOR INFLAMMATORY BOWEL-DISEASE
    HIRSCHFELD, S
    CLEARFIELD, HR
    AMERICAN FAMILY PHYSICIAN, 1995, 51 (08) : 1971 - 1975
  • [48] Therapeutic targets in inflammatory bowel disease
    Fluxa, Daniela
    Abreu, Maria T.
    REVISTA MEDICA CLINICA LAS CONDES, 2019, 30 (04): : 315 - 322
  • [49] Therapeutic peptides in inflammatory bowel disease
    Herrlinger, Klaus R.
    Stange, Eduard F.
    Fellermann, Klaus
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (04) : 455 - 466
  • [50] Therapeutic leukocytapheresis for inflammatory bowel disease
    Saniabadi, Abbi R.
    Hanai, Hiroyuki
    Fukunaga, Ken
    Sawada, Koji
    Shima, Chikako
    Bjarnason, Ingvar
    Lofberg, Robert
    TRANSFUSION AND APHERESIS SCIENCE, 2007, 37 (02) : 191 - 200
12345